HIV/Viral HepatitisÂ
Hepatitis means inflammation of the liver. This condition is most often caused by a virus. The most common causes of viral hepatitis are hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV). HBV and HCV are common among people who are at risk for, or living with, HIV. You can get some of viral hepatitis the same way you get HIV—through unprotected sexual contact and injection drug use. HAV causes a short-term severe illness, is usually spread when the virus is ingested from contact with food and objects (including injection drug equipment).
- Viral Hepatitis Transmission
- HAV
- HBV
- HCV
Related Conference of HIV/Viral HepatitisÂ
May 21-22, 2025
6th Annual Meeting on Infectious Diseases, Microbiology & Beneficial Microbes
Paris, France
May 21-22, 2025
12th International Conference on Infectious Diseases, Bacteriology and Antibiotics
Paris, France
June 16-17, 2025
5th International Conference on Microbiology and Infectious Diseases
Amsterdam, Netherlands
September 22-23, 2025
11th International Conference on Infectious and Rare Diseases
Vancouver, Canada
October 06-07, 2025
13th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
Las Vegas, USA
October 30-31, 2025
20th World Conference on Infectious Diseases, Prevention and Control
Paris, France
December 11-12, 2025
8th Annual Congress on Bacterial, Viral and Infectious Diseases
Prague, Czech Republic
HIV/Viral Hepatitis Conference Speakers
Recommended Sessions
- Advancements in treatment of AIDS and vaccines for immune system
- AIDS and behavioral studies
- Diagnostic Tools for Immunological and Virological Monitoring of HIV Infection
- Epidemiology of HIV infection
- Historical significance of immunological studies and treatment of AIDS
- HIV Prevention
- HIV/AIDS
- HIV/AIDS-Related Cancer
- HIV/Viral HepatitisÂ
- Immune Responses
- Immunology of HIV/AIDS, STDs & STIs
- Infectious pathogens
- Novel findings on virology & immunology
- Paediatric HIV Treatment Initiative
- Preventing Mother-to-Child Transmission of HIV
- Programs in biological Retrovirology
- Sexually transmitted diseases
- Super and Co-Infections
Related Journals
Are you interested in
- 1.Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2025 (Canada)
- 10. HIV/AIDS - Infectious Diseases_2025 (Canada)
- 11. Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2025 (Canada)
- 12. Respiratory Diseases - Infectious Diseases_2025 (Canada)
- 13. Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2025 (Canada)
- 14. Viral Infectious Diseases - Infectious Diseases_2025 (Canada)
- 15. Malaria and Hepatitis - Infectious Diseases_2025 (Canada)
- 16. Immunology of Infections - Infectious Diseases_2025 (Canada)
- 17. Vaccines and Vaccination - Infectious Diseases_2025 (Canada)
- 18. Tuberculosis - Infectious Diseases_2025 (Canada)
- 19. New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2025 (Canada)
- 2. Coronavirus(nCOV) - Infectious Diseases_2025 (Canada)
- 20. Nosocomial Infections - Infectious Diseases_2025 (Canada)
- 21. Parasitic Diseases - Infectious Diseases_2025 (Canada)
- 22. Surgical Site Infections - Infectious Diseases_2025 (Canada)
- 3. Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2025 (Canada)
- 4. Bacterial & Fungal Infectious Diseases - Infectious Diseases_2025 (Canada)
- 5. Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2025 (Canada)
- 6. Rare Diseases in Cancer and Aging - Infectious Diseases_2025 (Canada)
- 7. Global Trends in Emerging Infectious Diseases - Infectious Diseases_2025 (Canada)
- 8. Ebola and Zika Viral Infections - Infectious Diseases_2025 (Canada)
- 9. Clinical Research and Public Awareness - Infectious Diseases_2025 (Canada)
- A prospective study of dermatological infections - Emerging Infectious Diseases 2025 (Canada)
- Advancement in the Diagnosis of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Advancements in Vaccines and Therapeutics - Infectious Diseases 2025 (France)
- Alcohol and Drug Use - STD-HIV AIDS-2025 (USA)
- Antibiotics and Anti-viral - Euro Infectious Diseases 2025 (Netherlands)
- Antigen-Antibody Reactions - Infectious Diseases 2025 (France)
- Antimicrobial Resistance - Emerging Infectious Diseases 2025 (Canada)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2025 (UK)
- Bacterial Diseases - Euro Infectious Diseases 2025 (Netherlands)
- Bacterial Infections and Diseases - Infectious Diseases 2025 (France)
- Bacterial Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2025 (UK)
- Biofertilizers - Infectious Diseases 2025 (France)
- Biomarkers for Rare Disease Diagnosis and Treatment - Rare Diseases Congress 2025 (Netherlands)
- Biomedical Research - Rare Diseases Congress 2025 (Netherlands)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2025 (UK)
- Cardiovascular Diseases and Disorders - Emerging Infectious Diseases 2025 (Canada)
- Causes and Symptoms of Infections - Infection Prevention 2025 (UK)
- Causes and Symptoms of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Challenges of Living with a Rare Disease - Rare Diseases Congress 2025 (Netherlands)
- Changing Patterns of Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Clinical and Case Reports - INFECTIOUS DISEASES-2025 (France)
- Clinical Case Reports and Case Studies - Rare Diseases Congress 2025 (Netherlands)
- Clinical Management of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Clinical Research and Case Reports - STD-HIV AIDS-2025 (USA)
- Clinical Research on Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Co-infections Associated with STDs - STD-HIV AIDS-2025 (USA)
- Coronavirus Disease (COVID-19) - INFECTIOUS DISEASES-2025 (France)
- COVID-19 - Infectious Diseases 2025 (France)
- Covid_19 Infections - Infection Prevention 2025 (UK)
- Dental diseases & Infections - Emerging Infectious Diseases 2025 (Canada)
- Dermatological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Diabetes and Wound Care - Emerging Infectious Diseases 2025 (Canada)
- Diagnosis and Treatment - STD-HIV AIDS-2025 (USA)
- Diagnosis of infectious Diseases - Infection Prevention 2025 (UK)
- Diagnostics and Laboratory Techniques - Emerging Infectious Diseases 2025 (Canada)
- Different Types of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Drug Discovery for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Emerging and Re-Emerging Infections - Infection Prevention 2025 (UK)
- Emerging Technologies in Rare Disease Research - Rare Diseases Congress 2025 (Netherlands)
- Epidemiology - INFECTIOUS DISEASES-2025 (France)
- Epidemiology - Infection Prevention 2025 (UK)
- Epidemiology and Surveillance - Emerging Infectious Diseases 2025 (Canada)
- Functional Genomics and Gene Therapy for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Fungal Infections - Euro Infectious Diseases 2025 (Netherlands)
- Fungal Infections - Infectious Diseases 2025 (France)
- Fungal Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2025 (UK)
- Gene Expression - Infectious Diseases 2025 (France)
- Genetic Testing and Counselling of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Global Climatic Change and Emerging Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Health Security - Emerging Infectious Diseases 2025 (Canada)
- Global hotspots and correlates of emerging zoonotic diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Trends in Emerging Infections - Infection Prevention 2025 (UK)
- Health Economics and Market Access for Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Hepatitis Prevention - Infection Prevention 2025 (UK)
- HIV and Women's Health Issues - STD-HIV AIDS-2025 (USA)
- Human Monkeypox: An Emerging Zoonosis - Emerging Infectious Diseases 2025 (Canada)
- Immunizations and Vaccination - Infection Prevention 2025 (UK)
- Infection Control in Critical Care - Infection Prevention 2025 (UK)
- Infection Control Procedures - Infection Prevention 2025 (UK)
- Infection Prevention and Control - Euro Infectious Diseases 2025 (Netherlands)
- Infection Prevention and Control - Infection Prevention 2025 (UK)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2025 (France)
- Infectious Disease - Euro Infectious Diseases 2025 (Netherlands)
- Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Infectious Diseases and Cancer - Infectious Diseases 2025 (France)
- Infectious Diseases and Immune Deficiencies - Rare Diseases Congress 2025 (Netherlands)
- Infectious Diseases Epidemiology - INFECTIOUS DISEASES-2025 (France)
- Infectious Diseases Prevention, Control and Cure - INFECTIOUS DISEASES-2025 (France)
- Internal Medicine for Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Introduction and Causes of New Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Mutations - Infectious Diseases 2025 (France)
- Neuro Infections - Infection Prevention 2025 (UK)
- Neuro Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Neurological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Nosocomial Infections & Control - INFECTIOUS DISEASES-2025 (France)
- Nosocomial Infections and Control - Infection Prevention 2025 (UK)
- Nosocomial Infections and Their Control Strategies - Emerging Infectious Diseases 2025 (Canada)
- Ophthalmological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Orphan Drugs Potentiality - Rare Diseases Congress 2025 (Netherlands)
- Outbreak Investigation and Response - Emerging Infectious Diseases 2025 (Canada)
- Paediatric Infectious Diseases - Euro Infectious Diseases 2025 (Netherlands)
- Parasitic Infections - Euro Infectious Diseases 2025 (Netherlands)
- Parasitic Infections - Infectious Diseases 2025 (France)
- Parasitology & Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Pediatric HIV - STD-HIV AIDS-2025 (USA)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Pediatric Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Perspectives on Gastrointestinal Infections - Emerging Infectious Diseases 2025 (Canada)
- Pharmacology of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Plants Diseases and Infection Control - Infection Prevention 2025 (UK)
- Preventive Measures - Euro Infectious Diseases 2025 (Netherlands)
- Prion Diseases - Infectious Diseases 2025 (France)
- Probiotics and Prebiotics - Infectious Diseases 2025 (France)
- Public Health - Euro Infectious Diseases 2025 (Netherlands)
- Public Health - STD-HIV AIDS-2025 (USA)
- Public Health Policy and Preparedness - Emerging Infectious Diseases 2025 (Canada)
- Rare Autoimmune Disorders - Rare Diseases Congress 2025 (Netherlands)
- Rare Bone Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Cancer - Rare Diseases Congress 2025 (Netherlands)
- Rare Diseases and Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Rare Diseases of the Heart and Vessels - Rare Diseases Congress 2025 (Netherlands)
- Rare Neurological Disorders - Rare Diseases Congress 2025 (Netherlands)
- Rare Nutritional and Metabolic Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Paediatric Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Skin Diseases - Rare Diseases Congress 2025 (Netherlands)
- Recent Advancements - STD-HIV AIDS-2025 (USA)
- Regulatory Considerations for Developing Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Research on Medicine and Vaccine for Covid-19 - INFECTIOUS DISEASES-2025 (France)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2025 (UK)
- Respiratory tract infections - Euro Infectious Diseases 2025 (Netherlands)
- SARS and MERS: Recent Insights into Emerging Coronaviruses - Emerging Infectious Diseases 2025 (Canada)
- Sexual Health - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases (STDs) and Infections (STIs) - Infectious Diseases 2025 (France)
- Testing and Health Monitoring - STD-HIV AIDS-2025 (USA)
- The Science of SARS-CoV-2 - Emerging Infectious Diseases 2025 (Canada)
- Therapeutics and Treatment Strategies - Emerging Infectious Diseases 2025 (Canada)
- Transmission and Prevention - STD-HIV AIDS-2025 (USA)
- Treatment and Advanced Therapies for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Tropical diseases - Euro Infectious Diseases 2025 (Netherlands)
- Tropical Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Urinary Tract Infection - Euro Infectious Diseases 2025 (Netherlands)
- Vaccines - Euro Infectious Diseases 2025 (Netherlands)
- Vaccines and Immunization - Emerging Infectious Diseases 2025 (Canada)
- Vaccines and People with HIV - STD-HIV AIDS-2025 (USA)
- Vaccines and Vaccination - INFECTIOUS DISEASES-2025 (France)
- Vaccines and Vaccination for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Vector-borne diseases: New Approaches to Control Vector from disease transmission - Emerging Infectious Diseases 2025 (Canada)
- Veterinary Diseases - INFECTIOUS DISEASES-2025 (France)
- Veterinary Infectious Diseases - Infectious Diseases 2025 (France)
- Viral Infections - Euro Infectious Diseases 2025 (Netherlands)
- Viral Infections and Diseases - Infectious Diseases 2025 (France)
- Viral Infections and Recent Advancements - Infection Prevention 2025 (UK)
- Viral Infectious Diseases - INFECTIOUS DISEASES-2025 (France)